For the Inventor, By the Inventor

Enter assignee name

Londonderry, NH, United States of America

Diatide, Inc.

USPTO Granted Patents = 80

% Expired Patents = 3.8

Forward Citations = 382

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Richard T Dean (75 out of 88 patents)

John Lister-James (49 out of 57 patents)

William McBride (19 out of 23 patents)

4. Scott Buttram (16 out of 19 patents)

5. Edgar R Civitello (14 out of 14 patents)

6. Daniel A Pearson (8 out of 18 patents)

7. Larry R Bush (5 out of 5 patents)

8. Robert S Lees (3 out of 20 patents)

9. John E Cyr (3 out of 5 patents)

10. Brian R Moyer (2 out of 3 patents)

11. Duane L Venton (1 out of 5 patents)

12. Francis S Markland, Jr (1 out of 16 patents)

13. Edward R Civitello (1 out of 1 patent)

14. Anton J Hopfinger (1 out of 2 patents)

15. Guy Lebreton (1 out of 1 patent)

Core Competencies:

Radiopharmaceuticals

Technetium-99m

Somatostatin

Thrombus Imaging

Peptide-metal Chelate

Multimeric Agents

Imaging Inflammation

Calcitonin Receptor

Antithrombotic Agents

Radiolabeled Compounds

Diagnostic Imaging

Vasoactive Intestinal Peptides

80 patents: Sort by Forward Citations

1. 6989138 - Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans (2006-01-24),

2. 6902718 - Stabilization of radiopharmaceutical compositions using hydrophilic thioethers (2005-06-07),

3. 6881396 - Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans (2005-04-19),

4. 6667389 - Technetium-99m labeled peptides for imaging (2003-12-23),

5. 6509001 - Calcitonin receptor binding reagents (2003-01-21),

6. 6479032 - Calcitonin receptor binding reagents (2002-11-12),

7. 6241965 - Somatostatin derivatives and their radiolabelled products (2001-06-05),

8. 6214316 - Somatostatin analogs (2001-04-10),

9. 6183722 - Somatostatin analogs (2001-02-06),

10. 6150329 - Multimeric antithrombotic agents (2000-11-21),

11. 6136782 - Multimeric antithrombotic agents (2000-10-24),

12. 6113878 - Technetium-99m labeled peptides for imaging (2000-09-05),

13. 6107459 - Technetium-99m labeled peptides for diagnostic imaging (2000-08-22),

14. 6093383 - Bisamine bisthiol radiolabel binding moieties (2000-07-25),

15. 6086850 - Calcitonin receptor binding reagents (2000-07-11),

Company Overview

Diatide, Inc., based in Londonderry, NH, specializes in the development and manufacturing of innovative radiopharmaceuticals. The company focuses on advanced imaging techniques utilizing technetium-99m and peptide-metal chelates to enhance diagnostic capabilities in medical imaging. Their expertise extends to thrombus imaging and the exploration of somatostatin and calcitonin receptor-targeted agents, contributing to the advancement of imaging inflammation and other critical medical conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

80 Patents

#2 in Londonderry, NH

#35 in New Hampshire

#4,629 in US

#9,449 in the World

Londonderry, NH, United States of America

Diatide, Inc.

Forward Citations = 382

17 inventors:

Richard T Dean (75 out of 88 patents)

John Lister-James (49 out of 57 patents)

William McBride (19 out of 23 patents)

4. Scott Buttram (16 out of 19 patents)

5. Edgar R Civitello (14 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Diatide, Inc.. Retrieved from https://idiyas.com/company/diatide

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…